Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs To view or add a comment, sign in More Relevant Posts New Experimental Study | Diabetes & Lipid Management Can Cinnamomum zeylanicum (Ceylon cinnamon) enhance conventional therapy in diabetes
Tuunanen and Knuuti, 2011)
The mechanisms of glutamine uptake regulation are still being identified
At week 8, 51.6% patients treated with ALC met the primary endpoint, compared with 23.1% of patients in the placebo group
US$ 21.22
US$ 29.86
US$ 22.75
US$ 29.72
US$ 21.28
